drug · antibody
patient view →prasinezumab
Phase 3updated 2mo agoby Prothena Corp Plc🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Phase 3, with 1 investigational indication.
indications
indications
Parkinson's Disease
targets
Alpha-synuclein
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that